For Dogs Ā· WOOPFā„¢Care about your pet? Download ASK A VET!For Cats Ā· PURRZā„¢
ASK A VET
All articles
Ask A Vet
  • Exotic Animal Care
  • Large Animal Care
  • Nutrition
  • Pet Care
  • Tech & Tracking
  • Vet Tips

🩺 Severe Combined Immunodeficiency (SCID) in Horses: A Vet’s 2025 Guide by Dr Duncan Houston

🧬 Equine SCID: Hereditary autosomal recessive lack of B/T cells in Arabian foals—normal at birth, fatal by ~5 mo. šŸ” Signs: Infections (pneumonia, diarrhea), weight loss, low lymphocytes, failure to grow. 🧪 Diagnosis: PCR genetic test, bloodwork showing lymphopenia, low immunoglobulins. āš•ļø Prognosis: No cure—supportive care only; euthanasia often advised. šŸ›”ļø Prevention: Genetic screening, avoid carrierƗcarrier breedings. šŸ¤ Ask A Vet: Guides testing, breeding plans, remote monitoring & educational support.

Duncan Houston
Duncan Houston
Veterinarian Ā· Founder of ASK A VET
448 days ago7 min read

🩺 Severe Combined Immunodeficiency (SCID) in Horses: A Vet’s 2025 Guide | Dr Duncan Houston BVSc

Meta description: Learn about equine SCID—a fatal recessive immune disorder in Arabian foals. Discover signs, testing, breeding prevention strategies & Ask A Vet support.

1. 🧬 What Is SCID?

Severe Combined Immunodeficiency (SCID) is a genetic autosomal recessive condition mostly affecting Arabian and Arabian-cross foals. Foals are born seemingly healthy, but lack functional B and T lymphocytes due to a mutation preventing DNA-dependent protein kinase function :contentReference[oaicite:4]{index=4}. Without an adaptive immune system, foals cannot fight even routine infections.

2. āš ļø Why It’s So Serious

  • Foals appear normal at birth but quickly succumb to infections once maternal antibodies wane around 2–3 months :contentReference[oaicite:5]{index=5}.
  • Most affected foals die or are euthanized by 4–6 months due to pneumonia, diarrhea, or opportunistic infections :contentReference[oaicite:6]{index=6}.
  • There is no cure—stem cell therapy is experimental and not viable in equines.
  • SCID has been traced to the PRKDC gene mutation, with carrier rates around 8–25% before testing began, and ~17% more recently :contentReference[oaicite:7]{index=7}.

3. šŸ” Recognizing Clinical Signs

While initially asymptomatic, foals develop signs such as:

  • Persistent or recurrent pneumonia—cough, nasal discharge, respiratory distress :contentReference[oaicite:8]{index=8}.
  • Chronic diarrhea and weight loss despite good appetite.
  • Fever, stunted growth, lethargy, and poor immunity response to treatment.

Lab tests reveal lymphopenia (<1,000 lymphocytes/µL) and low immunoglobulins like IgM/IgA :contentReference[oaicite:9]{index=9}.

4. 🧪 Diagnostic Methods

  • Genetic PCR test: Screens for the PRKDC mutation; commercially available since 1997. Identifies affected foals and carriers :contentReference[oaicite:10]{index=10}.
  • Bloodwork: Confirms lymphocyte absence and low IgM—supports the genetic findings :contentReference[oaicite:11]{index=11}.
  • Differential diagnosis: Must be distinguished from failure of passive transfer (colostrum issues) or other immunodeficiencies.

5. šŸš‘ Treatment & Management

There is no cure. Supportive therapies may temporarily manage symptoms:

  • Antibiotics for bacterial pneumonia and infections.
  • IV fluids and probiotics for diarrhea and hydration.
  • But without functional immunity, infections recur relentlessly—leading to euthanasia :contentReference[oaicite:12]{index=12}.

6. šŸ›”ļø Prevention Through Breeding

  • Mandatory genetic testing of breeding stock (stallions and mares).
  • Avoid carrierƗcarrier matings—25% risk of affected foal, 50% carriers, 25% clear :contentReference[oaicite:13]{index=13}.
  • Carrier Ɨ clear breedings produce healthy foals but half of them will be carriers.
  • Breeding programs advocate phasing out carriers, or maintaining through informed breeding while preserving traits :contentReference[oaicite:14]{index=14}.
  • Registries like FOAL list SCID-test results to aid breeding decisions :contentReference[oaicite:15]{index=15}.

7. šŸ¤ Ask A Vet Tailored Support

With Ask A Vet, breeders and owners receive:

  • šŸ“‹ Guidance on when and how to test breeding stock.
  • šŸ“† Notifications for testing timelines and re-screening.
  • šŸ“‘ Interpretation of results and personalized breeding advice.
  • šŸŽ“ Webinars: "Genetics & SCID," "Breeding Strategies," "Carrier Management."
  • šŸ“Š Tools to track pedigrees, carrier status, and breeding outcomes over time.

8. ā“ Frequently Asked Questions

1. Are carriers affected?

No—carriers are asymptomatic and healthy. Concern only arises if carriers breed together :contentReference[oaicite:16]{index=16}.

2. Can SCID foals live?

No—absent immune function makes survival past a few months unsustainable. Euthanasia is humane and recommended.

3. Is there a cure?

No—stem-cell therapies have not proven viable in horses. Ongoing research may offer future gene therapy options.

4. What’s carrier frequency?

Before testing: ~8–25%; recent VetGen data: ~17% of Arabians are carriers; 0.3% are affected :contentReference[oaicite:17]{index=17}.

5. Should all Arabians be tested?

Yes—every breeding horse should be tested to eliminate risk and protect future generations.

9. āœ… Final Takeaway

SCID remains one of the most severe genetic threats in Arabian breeding. Thankfully, simple genetic testing can prevent all future cases. As Dr Duncan Houston, I recommend breeders partner with Ask A Vet for comprehensive test guidance, breeding management, and long-term pedigree planning to secure healthy foal outcomes through 2025 and beyond.

ASK A VET GPS Tracker
Know how they are, wherever they are

The ASK A VETā„¢ Tracker logs live location and activity trends, so a change in routine never goes unnoticed.

View tracker
Dr Duncan Houston
About the author
Dr Duncan Houston
Veterinarian Ā· Founder of ASK A VET

Every ASK A VET article is written and reviewed by qualified veterinarians.

Sign up for Ask A Vet news

Stay in the Pack

Get the latest news, vet-approved tips and early access to new gear — straight to your inbox.

By subscribing you agree to our Terms & Conditions and Privacy Policy.